Clincosm LogoSign in Get a demo

multiple sclerosis, secondary progressive

Showing 1 - 24 of 24
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in Palo Alto

Not yet recruiting
  • Multiple Sclerosis
  • +2 more
  • KYV-101 anti-CD19 CAR-T cell therapy
  • Standard lymphodepletion regimen
  • Palo Alto, California
    Stanford Multiple Sclerosis Center
Nov 13, 2023

Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis Trial in Warsaw (Cladribine Subcutaneous Injection, 0.9% Chloride

Recruiting
  • Multiple Sclerosis, Secondary Progressive
  • Multiple Sclerosis
  • Cladribine Subcutaneous Injection
  • 0.9% Chloride Injection Sodium
  • Warsaw, Mazowieckie, Poland
    Institute of Psychiatry and Neurology
Jul 26, 2023

Multiple Sclerosis (MS) Patients

Not yet recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • +2 more
    • (no location specified)
    Dec 15, 2022

    Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Secondary Progressive Trial in Tokyo (OCH-NCNP1, Placebo)

    Active, not recruiting
    • Multiple Sclerosis, Relapsing-Remitting
    • Multiple Sclerosis, Secondary Progressive
    • Tokyo, Japan
      National Center of Neurology and Psychiatry
    Sep 28, 2022

    Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis, Primary Progressive

    Completed
    • Multiple Sclerosis, Relapsing-Remitting
    • +2 more
    • 18F-DPA-714 and 18F-FDG
    • Paris, France
    • +1 more
    Sep 14, 2022

    Secondary Progressive Multiple Sclerosis, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis Trial in Salt Lake City

    Recruiting
    • Secondary Progressive Multiple Sclerosis
    • +2 more
    • Ferumoxytol infusion
    • +2 more
    • Salt Lake City, Utah
      University of Utah Health Imaging and Neurosciences Center
    Jun 22, 2022

    Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis, Multiple Sclerosis, Primary Progressive Trial in Porto Alegre

    Not yet recruiting
    • Multiple Sclerosis, Chronic Progressive
    • +3 more
    • Nordic Walking (NWG)
    • +2 more
    • Porto Alegre, Rio Grande Do Sul, Brazil
      Universidade Federal do Rio Grande do Sul
    May 17, 2022

    Multiple Sclerosis, Secondary Progressive Trial in Calgary (Hydroxychloroquine Pill, Indapamide Pill)

    Recruiting
    • Multiple Sclerosis, Secondary Progressive
    • Hydroxychloroquine Pill
    • Indapamide Pill
    • Calgary, Alberta, Canada
      Foothills Medical Centre
    May 16, 2022

    Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in San Francisco

    Recruiting
    • Multiple Sclerosis
    • +2 more
    • N-acetyl cysteine
    • Placebo
    • San Francisco, California
      University of California, San Francisco
    Mar 22, 2022

    Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in Marseille, Rennes (Magnetic

    Recruiting
    • Multiple Sclerosis, Primary Progressive
    • Multiple Sclerosis, Secondary Progressive
    • Magnetic Resonance Imaging
    • +3 more
    • Marseille, France
    • +1 more
    Jan 14, 2022

    MS-ResearchBiomarkerS

    Recruiting
    • Multiple Sclerosis
    • +10 more
      • Los Angeles, California
        Cedars-Sinai Medical Center
      Jan 26, 2022

      Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis, Primary Progressive

      Completed
      • Multiple Sclerosis, Relapsing-Remitting
      • +2 more
      • Baltimore, Maryland
        Johns Hopkins University School of Medicine
      Dec 30, 2021

      MS - a Prospective Cohort Study

      Active, not recruiting
      • Multiple Sclerosis, Relapsing-Remitting
      • +2 more
      • PASS-MS
      • Berlin, Germany
        Experimental and Clinical Research Center, Studienambulanz Neuro
      Aug 9, 2021

      Cortical Lesions in Patients With Multiple Sclerosis

      Completed
      • Multiple Sclerosis
      • +2 more
        • Hvidovre, Denmark
          Danish Research Centre for Magnetic Resonance
        Apr 6, 2021

        Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Secondary Progressive Trial in Amsterdam (DMT)

        Recruiting
        • Multiple Sclerosis
        • +2 more
        • Amsterdam, Netherlands
          Amsterdam UMC
        Oct 13, 2020

        Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in United States (ibudilast, Placebo

        Completed
        Has Results
        • Multiple Sclerosis, Primary Progressive
        • Multiple Sclerosis, Secondary Progressive
        • Birmingham, Alabama
        • +27 more
        Jul 13, 2020

        Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Relapse Free Trial in

        Completed
        • Multiple Sclerosis, Secondary Progressive
        • +2 more
        • Sofia, Bulgaria
        • +7 more
        Apr 3, 2020

        Multiple Sclerosis, Secondary Progressive Trial in Calgary (Domperidone)

        Completed
        • Multiple Sclerosis, Secondary Progressive
        • Calgary, Alberta, Canada
          Calgary MS Clinic at Foothills Medical Centre
        Feb 20, 2020

        Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis, Primary Progressive

        Completed
        • Multiple Sclerosis, Relapsing-Remitting
        • +2 more
        • Baltimore, Maryland
          The Johns Hopkins Hospital
        Feb 8, 2018

        Multiple Sclerosis, Secondary Progressive Trial in Worldwide (dimethyl fumarate, Placebo)

        Terminated
        Has Results
        • Multiple Sclerosis, Secondary Progressive
        • dimethyl fumarate
        • Placebo
        • Long Beach, California
        • +17 more
        Mar 27, 2017

        Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Secondary Progressive Trial in Bellaire, Houston (Tovaxin

        Completed
        • Multiple Sclerosis, Relapsing-Remitting
        • Multiple Sclerosis, Secondary Progressive
        • Tovaxin Autologous T Cell Vaccine
        • Bellaire, Texas
        • +1 more
        Jan 9, 2017

        Primary Progressive Multiple Sclerosis, Multiple Sclerosis, Secondary Progressive Trial in Santiago (Andrographolides, )

        Unknown status
        • Primary Progressive Multiple Sclerosis
        • Multiple Sclerosis, Secondary Progressive
        • Santiago, Metropolitana, Chile
          Multiple Sclerosis Centre, Pontificia Universidad Catolica de Ch
        Oct 24, 2014

        Bayer/Cognitive Assessments With Multiple Sclerosis Subjects

        Completed
        • Multiple Sclerosis, Relapsing-remitting
        • Multiple Sclerosis, Secondary Progressive
          • Louisville, Kentucky
            University of Louisville
          Oct 31, 2013

          Multiple Sclerosis, Secondary Progressive Trial (MBP8298)

          Terminated
          • Multiple Sclerosis, Secondary Progressive
          • (no location specified)
          Aug 12, 2009